WESPAC Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $734K | Hold |
2,087
| – | – | 0.4% | 82 |
|
|
2025
Q4 | $683K | Buy |
+2,087
| New | +$662K | 0.37% | 82 |
|
|
2025
Q1 | – | Sell |
-2,978
| Closed | -$776K | – | 156 |
|
|
2024
Q4 | $776K | Sell |
2,978
-1,203
| -29% | -$357K | 0.57% | 65 |
|
|
2024
Q3 | $1.35M | Buy |
4,181
+985
| +31% | +$322K | 1% | 30 |
|
|
2024
Q2 | $999K | Sell |
3,196
-1,241
| -28% | -$365K | 0.78% | 39 |
|
|
2024
Q1 | $1.26M | Buy |
4,437
+349
| +9% | +$102K | 0.73% | 43 |
|
|
2023
Q4 | $1.18M | Buy |
+4,088
| New | +$1.11M | 0.82% | 39 |
|
|
2020
Q1 | – | Sell |
-2,941
| Closed | -$709K | – | 52 |
|
|
2019
Q4 | $709K | Sell |
2,941
-367
| -11% | -$80.9K | 0.69% | 53 |
|
|
2019
Q3 | $640K | Buy |
+3,308
| New | +$635K | 0.64% | 57 |
|
|
2019
Q2 | – | Sell |
-12,724
| Closed | -$2.39M | – | 108 |
|
|
2019
Q1 | $2.39M | Buy |
12,724
+23
| +0.2% | +$4.39K | 1.65% | 25 |
|
|
2018
Q4 | $2.47M | Sell |
12,701
-776
| -6% | -$151K | 2.4% | 14 |
|
|
2018
Q3 | $2.79M | Buy |
13,477
+4,522
| +50% | +$891K | 1.63% | 15 |
|
|
2018
Q2 | $1.65M | Sell |
8,955
-4,156
| -32% | -$735K | 1.71% | 22 |
|
|
2018
Q1 | $2.23M | Buy |
13,111
+1,303
| +11% | +$239K | 1.36% | 27 |
|
|
2017
Q4 | $2.05M | Buy |
+11,808
| New | +$2.09M | 1.9% | 11 |
|
|
2016
Q4 | – | Sell |
-9,616
| Closed | -$1.6M | – | 107 |
|
|
2016
Q3 | $1.6M | Sell |
9,616
-675
| -7% | -$114K | 1.81% | 13 |
|
|
2016
Q2 | $1.57M | Buy |
10,291
+1,813
| +21% | +$282K | 1.62% | 18 |
|
|
2016
Q1 | $1.27M | Buy |
+8,478
| New | +$1.26M | 1.58% | 23 |
|
|
2015
Q2 | – | Sell |
-8,140
| Closed | -$1.3M | – | 115 |
|
|
2015
Q1 | $1.3M | Sell |
8,140
-2,083
| -20% | -$328K | 0.99% | 40 |
|
|
2014
Q4 | $1.63M | Buy |
10,223
+3,751
| +58% | +$584K | 1.14% | 33 |
|
|
2014
Q3 | $909K | Buy |
6,472
+1,590
| +33% | +$208K | 0.73% | 56 |
|
|
2014
Q2 | $578K | Sell |
4,882
-961
| -16% | -$111K | 0.66% | 63 |
|
|
2014
Q1 | $721K | Buy |
5,843
+716
| +14% | +$86.8K | 0.62% | 68 |
|
|
2013
Q4 | $585K | Buy |
+5,127
| New | +$583K | 0.49% | 88 |
|
|
2013
Q3 | – | Sell |
-2,264
| Closed | -$223K | – | 112 |
|
|
2013
Q2 | $223K | Buy |
+2,264
| New | +$235K | 0.34% | 85 |
|
Other funds holding AMGN
VCM
VPM
WESPAC Advisors's AMGN Position: Q1 2026 in Review
WESPAC Advisors held its Amgen (AMGN) position steady in Q1 2026 at 2,087 shares worth $734K. The position accounts for 0.4% of the portfolio, ranked #82.
WESPAC Advisors first reported a position in AMGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.79M in Q3 2018. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- WESPAC Advisors held 2,087 shares of Amgen worth $734K as of Q1 2026.
- WESPAC Advisors left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.4% of WESPAC Advisors's portfolio in Q1 2026, its #82 holding.
- WESPAC Advisors first reported a position in Amgen in Q2 2013 and has held it in 25 quarters since.
- WESPAC Advisors's Amgen position peaked at $2.79M in Q3 2018.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on WESPAC Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.